Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: A case-controlled study

Clinical Gastroenterology and Hepatology

Volumn 3, Issue 9, 2005, Pages 918-925

  Biselli, Maurizio ^a   Andreone, Pietro ^a,f   Gramenzi, Annagiulia ^a   Trevisani, Franco ^a   Cursaro, Carmela ^a   Rossi, Cristina ^a   Rosellini, Salvatore Ricca ^b   Cammà, Carlo ^c   Lorenzini, Stefania ^a   Stefanini, Giuseppe Francesco ^d   Gasbarrini, Giovanni ^e   Bernardi, Mauro ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Ospedale di Forli   (Italy)

^c CNR   (Italy)

^d Ospedale di Faenza   (Italy)

^e CATHOLIC UNIVERSITY   (Italy)

^f UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; EPIRUBICIN;

ADULT; AGE DISTRIBUTION; AGED; ALOPECIA; ANEMIA; ARTICLE; ASCITES; BRAIN DISEASE; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHOLECYSTITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FEVER; FOLLOW UP; HEADACHE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PANCREATITIS; PNEUMONIA; PREDICTION; PROGNOSIS; SEX RATIO; SUBPHRENIC ABSCESS; SURVIVAL; TACHYCARDIA; VOMITING;

AGED; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CAUSE OF DEATH; CHEMOEMBOLIZATION, THERAPEUTIC; EPIRUBICIN; FEMALE; FOLLOW-UP STUDIES; HEPATIC ARTERY; HUMANS; ITALY; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 24044499970     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-3565(05)00425-8     Document Type: Article

References (49)

1. D.M. Parkin, F. Bray, J. Ferlay Estimating the world cancer burden GLOBOCAN 2000 Int J Cancer 94 2001 153 156
2. F. Trevisani, P. Caraceni, M. Bernardi Gross pathologic types of hepatocellular carcinoma in Italian patients relationship with demographic environmental and clinical factors Cancer 72 1993 1557 1563
3. Y. Akashi, C. Koreeda, S. Enomoto Prognosis of unresectable hepatocellular carcinoma. An evaluation based on multivariate analysis of 90 cases Hepatology 14 1991 262 268
4. K.M. Olthoff Surgical option for hepatocellular carcinoma resection and transplantation Liver Transpl Surg 4 1998 98 104
5. V. Mazzaferro, E. Regalia, R. Doci Liver transplantation for treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 1996 693 699
6. H. Bismuth, P.E. Majno, R. Adam Liver transplantation for hepatocellular carcinoma Gastroenterology 108 1995 768 775
7. M.E. Schwartz Primary hepatocellular carcinoma transplant versus resection Semin Liver Dis 14 1994 135 139
8. J. Bruix, J.M. Llovey Prognostic prediction and treatment strategy in hepatocellular carcinoma Hepatology 35 2002 519 524
9. C.L. Liu, S.T. Fan Nonresectional therapies for hepatocellular carcinoma Am J Surg 173 1997 358 365
10. Groupe d'Etude et de Treatment du Carcinome Hepatocellulaire A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma N Engl J Med 332 1995 1256 1261
11. G. Pelletier, A. Roche, O. Ink A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma J Hepatol 11 1990 181 184
12. G. Pelletier, M. Ducreux, F. Gay Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization a multicenter randomized trial J Hepatol 29 1998 129 134
13. J.F. Geshwind, D.E. Ramsey, M.A. Choti Chemoembolization of hepatocellular carcinoma results of a metaanalysis Am J Clin Oncol 26 2003 344 349
14. J.M. Llovet, J. Bruix Systematic review of randomized trials for unresectable hepatocellular carcinoma chemoembolization improves survival Hepatology 37 2003 429 442
15. C. Cammà, F. Schepis, A. Orlando Transarterial chemoembolization in patients with unresectable hepatocellular carcinoma a meta-analysis of randomized controlled trials Radiology 224 2002 47 54
16. C.M. Lo, H. Ngan, W.K. Tso Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology 35 2002 1164 1171
17. J.M. Llovet, M.I. Real, X. Montana Barcelona Liver Cancer Group Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma a randomised controlled trial Lancet 359 2002 1734 1739
18. R.N. Pugh, I.M. Murray-Lyon, J.L. Dawson Transection of the oesophagus for bleeding oesophageal varices Br J Surg 60 1973 646 649
19. K. Okuda, R.L. Peters, I.W. Simson Gross anatomical features of hepatocellular carcinoma from three disparate geographic areas proposal of new classification Cancer 54 1984 2165 2173
20. The Cancer of the Liver Italian Program (CLIP) Investigators A new prognostic system for hepatocellular carcinoma a retrospective study of 435 patients Hepatology 28 1998 751 755
21. The Cancer of the Liver Italian Program (CLIP) Investigators Prospective validation of the CLIP score a new prognostic system for patients with cirrhosis and hepatocellular carcinoma Hepatology 31 2000 840 845
22. I. Levy, M. Sherman Staging of hepatocellular carcinoma assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto Gut 50 2002 881 885
23. F. Farinati, M. Rinaldi, S. Gianni How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system Cancer 89 2000 2266 2273
24. G.F. Stefanini, P. Amorati, M. Biselli Efficacy of transarterial targeted treatments on survival of patients with hepatocellular carcinoma. An Italian experience Cancer 75 1995 2427 2434
25. S. Higashi, M. Shimizu, T. Nakashima Arterial-injection chemotherapy for hepatocellular carcinoma using monodispersed poppy-seed oil microdroplets containing fine aqueous vesicles of epirubicin. Initial medical application of a membrane-emulsification technique Cancer 75 1995 1245 1254
26. E. Kaplan, P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
27. N. Mantel, M. Haenszel Statistical aspects of the analysis of data from retrospective studies of disease J Natl Cancer Inst 22 1959 719 748
28. D.R. Cox Regression models and life tables J R Stat Soc B 34 1972 187 220
29. F. Trevisani, S. De Notariis, C. Rossi Randomized control trials on chemoembolization for hepatocellular carcinoma. Is there room for new studies? J Clin Gastroenterol 32 2001 383 389
30. C. Breedis, G. Young The blood supply of neoplasm in liver Am J Pathol 30 1954 969 985
31. S. Bhattacharya, B. Davidson, A.P. Dhillon Blood supply of early hepatocellular carcinoma Semin Liver Dis 15 1995 390 401
32. T. Furuta, T. Kanematsu, S. Kakizoe Selective effect of doxorubicin suspended in lipiodol on VX2 carcinoma in rabbits J Surg Oncol 39 1988 229 234
33. K. Takayasu, Y. Shima, Y. Muramatsu Hepatocellular carcinoma treatment with intraarterial iodized oil with and without chemotherapeutic agents Radiology 163 1987 345 351
34. J.C. Trinchet, M. Beaugrand Treatment of hepatocellular carcinoma in patients with cirrhosis J Hepatol 27 1997 756 765
35. A. Roche Therapy of HCC-TACE for liver tumor Hepatogastroenterology 48 2001 3 7
36. D. Vetter, J.J. Wenger, J.M. Bergier Transcatheter oily chemoembolization in the management of advanced hepatocellular carcinoma in cirrhosis results of a Western comparative study in 60 patients Hepatology 13 1991 427 433
37. K.E. Stuart, A.J. Anand, R.L. Jenkins Hepatocellular carcinoma in the United States prognostic features, treatment outcome, and survival Cancer 77 1996 2217 2222
38. D.M. Rose, W.C. Chapman, A.T. Brockenbrough Transcatheter arterial chemoembolization as primary treatment for hepatocellular carcinoma Am J Surg 177 1999 405 410
39. S.E. Cohen, R. Safadi, A. Verstandig Liver-spleen infarcts following transcatheter chemoembolization a case report and review of the literature on adverse effects Dig Dis Sci 42 1997 938 943
40. S. Markovic, E. Gadzijev, B. Stabuc Treatment options in western hepatocellular carcinoma a prospective study of 224 patients J Hepatol 29 1998 650 659
41. J.P. Bronowicki, D. Vetter, F. Dumas Transcatheter oily chemoembolization for hepatocellular carcinoma a 4-year study of 127 patients Cancer 74 1994 16 24
42. J.P. Bronowicki, K. Boudjema, L. Chone Comparison of resection, liver transplantation and transcatheter oily chemoembolization in the treatment of hepatocellular carcinoma J Hepatol 24 1996 293 300
43. A. Pawarode, P. Tangkijvanich, N. Voravud Outcomes of primary hepatocellular carcinoma treatment an 8-year experience with 368 patients in Thailand J Gastroenterol Hepatol 15 2000 860 864
44. B. Sangro, M. Herraiz, M.A. Martinez-Gonzalez Prognosis of hepatocellular carcinoma in relation to treatment a multivariate analysis of 178 patients from a single European institution Surgery 124 1998 575 583
45. M.F. Yuen, A.O. Chan, B.C. Wong Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B results of a comparative study in 96 Chinese patients Am J Gastroenterol 98 2003 1181 1185
46. G.F. Stefanini, M. Biselli, F.G. Foschi Alcohol consumption influences the survival of patients with hepatocellular carcinoma treated with endoarterial therapy Hepatology 26 Suppl 4 1997 475
47. L. Llado, J. Virgili, J. Figueras A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization Cancer 88 2000 50 57
48. C.B. O'Suilleabhain, R.T.P. Poon, J.L. Yong Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma Br J Surg 90 2003 325 331
49. O. Ernst, G. Sergent, D. Mizrahi Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization comparison of planned periodic chemoembolization and chemoembolization based on tumor response AJR Am J Roentgenol 172 1999 59 64